B Oliva
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Biotechnology top 5%
- Listeria monocytogenes in Food Safety
Papers in
-
- Antibiotic Resistance in Bacteria 14
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- Ian Chopra (5 shared papers)I. Chopra (7 shared papers)Alex J. O’Neill (4 shared papers)Paolo Aureli (4 shared papers)Anna Maria Ferrini (4 shared papers)Peter J. O’Hanlon (2 shared papers)Keith Miller (2 shared papers)George A. Ellestad (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (10 papers)Journal of Antimicrobial Chemotherapy (5 papers)Chemotherapy (2 papers)Journal of Bacteriology (2 papers)Journal of Medical Microbiology (1 paper)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
B Oliva
29 papers receiving 875 citations
Peers
Comparison fields: 5 of 81
- Molecular Medicine 187
- Biotechnology 114
- Microbiology 67
- Infectious Diseases 181
- Endocrinology 49
Countries citing papers authored by B Oliva
This map shows the geographic impact of B Oliva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Oliva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Oliva more than expected).
Fields of papers citing papers by B Oliva
This network shows the impact of papers produced by B Oliva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Oliva. The network helps show where B Oliva may publish in the future.
Co-authors
The 25 scholars most cited alongside B Oliva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 91 | |
| 2 | 1991 | 78 | |
| 3 | 2000 | 76 | |
| 4 | 1992 | 73 | |
| 5 | 2003 | 71 | |
| 6 | 2004 | 63 | |
| 7 | 1995 | 57 | |
| 8 | 2003 | 50 | |
| 9 | 2004 | 48 | |
| 10 | 2003 | 48 | |
| 11 | 2004 | 33 | |
| 12 | 1992 | 33 | |
| 13 | 2006 | 31 | |
| 14 | 2002 | 23 | |
| 15 | 1979 | 21 | |
| 16 | 1989 | 20 | |
| 17 | 1995 | 17 | |
| 18 | 1987 | 16 | |
| 19 | 1993 | 12 | |
| 20 | 1998 | 11 |
About B Oliva
B Oliva is a scholar working on Molecular Medicine, Molecular Biology, Infectious Diseases, Pharmacology and Food Science, having authored 33 papers that have together received 903 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Mycobacterium research and diagnosis (5 papers), Cancer therapeutics and mechanisms (5 papers), Bacterial Genetics and Biotechnology (4 papers), Antimicrobial Peptides and Activities (3 papers) and Salmonella and Campylobacter epidemiology (3 papers). The work is most often cited by research in Molecular Medicine (187 citations), Biotechnology (114 citations), Microbiology (67 citations), Infectious Diseases (181 citations) and Endocrinology (49 citations). B Oliva has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Ian Chopra, I. Chopra, Alex J. O’Neill, Paolo Aureli, Anna Maria Ferrini, Peter J. O’Hanlon, Keith Miller, George A. Ellestad, Robert Cassels and Donald P. Knowles. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Chemotherapy, Journal of Bacteriology and Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.